Merck MRK paid Crossroads Strategies $40K for lobbying in Q3 2024 · Health Issues, Medicare and 4 more issues

Trade details

Type: Lobbying report
Amount: $40,000
Quarter: Q3 2024
Stock: Merck MRK
Client: Merck
Reported: 24/10/20

Up 0.0% from last quarter

What else happened in Merck around then

Filed or reported within 30 days of the trade day · 24/08/31~24/10/30

Merck's other lobbying reports

Merck
LobbyingMerck
Lobbying
Merck
MRK
$50K
$50K
Reported 07/20
for Q2
Merck
LobbyingMerck
Lobbying
Merck
MRK
$50K
$50K
Reported 07/20
for Q2
Merck
LobbyingMerck
Lobbying
Merck
MRK
$50K
$50K
Reported 07/20
for Q2
Merck
LobbyingMerck
Lobbying
Merck
MRK
$50K
$50K
Reported 07/20
for Q2
Merck
LobbyingMerck
Lobbying
Merck
MRK
$50K
$50K
Reported 07/20
for Q2

Merck MRK paid Crossroads Strategies $40K for lobbying in Q3 2024 · Health Issues, Medicare and 4 more issues | Whalegun